MICHAEL S PERRY

CIK 1250379 · Chief Executive Officer · last filed 2025-12-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.87M

Companies

6

Total Filings

52

Lifetime Open-Market Net

-$11.94M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARWR Director 123,059 $74.52 $9.17M -$8.32M 24 2025-12-18
RCEL Chief Executive Officer 406,525 $3.91 $1.59M -$3.81M 9 2022-11-22
ARMP Director $7.58 $0 1 2019-05-24
Armata Pharmaceuticals, Inc. (APHB) Delisted Director 411,335 $200.0K 3 2018-03-26
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted President & CMO 81,860 -$16.9K 7 2011-04-14
TGEN Director 20,000 $5.73 $114.6K $0 3 2009-06-02

Recent Filings · Page 4 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-02-10 ARWR Grant (A) +15,000 $0 EDGAR
2013-09-24 ARWR Grant (A) $0 EDGAR
2013-05-08 ARWR Grant (A) $0 EDGAR
2013-04-01 ARWR Grant (A) $0 EDGAR
2013-03-25 ARWR Grant (A) $0 EDGAR
2012-10-02 ARWR Grant (A) $0 EDGAR
2012-03-27 Exer (M) +2,800 $0
2012-03-27 Sell (S) −1,599 -$1.3K
2012-02-21 ARWR Grant (A) $0 EDGAR
2012-02-17 Sell (S) −6,346 -$5.5K
Showing 3140 of 52
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.